Literature DB >> 11782107

Maternal cytokine levels during pregnancy and adult psychosis.

S L Buka1, M T Tsuang, E F Torrey, M A Klebanoff, R L Wagner, R H Yolken.   

Abstract

We investigated levels of maternal cytokines in late pregnancy in relation to the subsequent development of adult schizophrenia and other psychoses in their offspring. The sample included the mothers of 27 adults with schizophrenia and other psychotic illnesses and 50 matched unaffected controls from the Providence cohort of the Collaborative Perinatal Project. Serum samples were analyzed for interleukin 1 beta (IL-1-beta), interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin 8 (IL-8), and tumor necrosis factor alpha (TNF-alpha) by enzyme immunoassay. Maternal levels of TNF-alpha were significantly elevated among the case series (t = 2.22, p =.04), with evidence of increasing odds of psychosis in relation to higher cytokine levels. We did not find significant differences between case and control mothers in the serum levels of IL-1, IL-2, IL-6, or IL-8. These data support previous clinical investigations reporting maternal infections during pregnancy as a potential risk factor for psychotic illness among offspring. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782107     DOI: 10.1006/brbi.2001.0644

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  113 in total

1.  Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood.

Authors:  Philip R Nielsen; Thomas M Laursen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

3.  Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy.

Authors:  Tamara S Bodnar; Charlis Raineki; Wladimir Wertelecki; Lyubov Yevtushok; Larisa Plotka; Natalya Zymak-Zakutnya; Gordon Honerkamp-Smith; Alan Wells; Matthieu Rolland; Todd S Woodward; Claire D Coles; Julie A Kable; Christina D Chambers; Joanne Weinberg
Journal:  Brain Behav Immun       Date:  2018-05-05       Impact factor: 7.217

Review 4.  The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development.

Authors:  Regina Sullivan; Donald A Wilson; Joram Feldon; Benjamin K Yee; Urs Meyer; Gal Richter-Levin; Avital Avi; Tsoory Michael; Michael Gruss; Jörg Bock; Carina Helmeke; Katharina Braun
Journal:  Dev Psychobiol       Date:  2006-11       Impact factor: 3.038

Review 5.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

6.  Covariance modeling of MRI brain volumes in memory circuitry in schizophrenia: Sex differences are critical.

Authors:  Brandon Abbs; Lichen Liang; Nikos Makris; Ming Tsuang; Larry J Seidman; Jill M Goldstein
Journal:  Neuroimage       Date:  2011-04-08       Impact factor: 6.556

Review 7.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

8.  Prenatal infection as a risk factor for schizophrenia.

Authors:  Alan S Brown
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

9.  Psychosocial influences on immunity, including effects on immune maturation and senescence.

Authors:  Christopher L Coe; Mark L Laudenslager
Journal:  Brain Behav Immun       Date:  2007-08-15       Impact factor: 7.217

Review 10.  Infections and Brain Development.

Authors:  Christina N Cordeiro; Michael Tsimis; Irina Burd
Journal:  Obstet Gynecol Surv       Date:  2015-10       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.